Spatial heterogeneity of antibody-drug conjugate targets in pancreatic ductal adenocarcinoma. [PDF]
Sabtan D +10 more
europepmc +1 more source
Ubiquitination-Associated Ductal-Fibroblast Crosstalk Shapes Tumor Progression and Prognosis in Pancreatic Ductal Adenocarcinoma. [PDF]
Fu Y +9 more
europepmc +1 more source
Expression of Claudin-18.2 in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. [PDF]
Al Subhi M +6 more
europepmc +1 more source
Impact of Cirrhosis Outcome Risk Estimator Score on Outcomes Following Pancreatectomy for Resectable Pancreatic Ductal Adenocarcinoma. [PDF]
Yasui K +5 more
europepmc +1 more source
Evaluation of Self-Illuminating Nanoconjugates Against Pancreatic Ductal Adenocarcinoma. [PDF]
Abal-Sanisidro M +9 more
europepmc +1 more source
Construction of an efferocytosis related signature to predict the prognosis of pancreatic ductal adenocarcinoma. [PDF]
Li J, Du Z, Liu X, Pan T, Zheng Y, He Y.
europepmc +1 more source
Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma. [PDF]
Maia A +10 more
europepmc +1 more source
Liquid Biopsy-Derived microRNAs in Pancreatic Ductal Adenocarcinoma: Matrix-Specific Evidence and Translational Challenges. [PDF]
Wołyniak M +4 more
europepmc +1 more source
Futility of resection after neoadjuvant therapy in pancreatic ductal adenocarcinoma. [PDF]
Luo HT +6 more
europepmc +1 more source

